Gregory Cote to Biomarkers, Tumor
This is a "connection" page, showing publications Gregory Cote has written about Biomarkers, Tumor.
Connection Strength
1.056
-
Response to Le Large et al. Am J Gastroenterol. 2015 May; 110(5):769-70.
Score: 0.370
-
A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile. Am J Gastroenterol. 2014 Dec; 109(12):1942-52.
Score: 0.357
-
Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study. Int J Cancer. 2017 09 01; 141(5):905-915.
Score: 0.107
-
Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11. Sci Rep. 2017 03 06; 7:43941.
Score: 0.105
-
Prognostic significance of miRNA-1 (miR-1) expression in patients with chordoma. J Orthop Res. 2014 May; 32(5):695-701.
Score: 0.085
-
Clinical and Molecular Analysis of Pathologic Fracture-associated Osteosarcoma: MicroRNA profile Is Different and Correlates with Prognosis. Clin Orthop Relat Res. 2019 Sep; 477(9):2114-2126.
Score: 0.031